MedTech Showcase 2020

By January 6, 2020 Event, Media

Gabe Musso, Chief Scientific Officer will be leading a presentation on how BioSymetrics is redefining AI-based Drug Discovery during the MedTech Showcase at #JPM2020.  Topics will include how phenotype prediction can increase certainty of compound effects in vivo, identify off-target effects, reduce toxicity and shorten the path to market.

Or click here to contact us/schedule a meeting.